The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.85
Bid: 17.90
Ask: 18.50
Change: -0.65 (-3.51%)
Spread: 0.60 (3.352%)
Open: 17.90
High: 17.90
Low: 17.50
Prev. Close: 18.50
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

17 Feb 2022 07:00

RNS Number : 9274B
BATM Advanced Communications Ld
17 February 2022
 

LEI: 213800FLQUB9J289RU66

17 February 2022

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Trading Update and Notice of Results

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice that the Group will be announcing its results for the year ended 31 December 2021 on Monday 28 February 2022.

 

The Group is delighted to announce that it expects to report full year revenue and EBITDA for 2021 slightly ahead of market expectations (which were raised during the year on 23 August 2021) reflecting strong growth from ongoing operations* with increased revenue in both divisions. In particular, this has been driven by significant growth in the Group's Diagnostics unit of the Bio-Medical division.

 

Looking ahead, the Group entered the new year with a substantially higher backlog from ongoing operations than at the same point of the prior year and the strong momentum of 2021 has continued. Accordingly, the Group remains on track to deliver significant growth for full year 2022 in line with market expectations.

 

Further detail will be provided in the Group's full year results announcement on 28 February 2022.

 

Presentations to analysts and investors

 

Dr Zvi Marom, Chief Executive Officer, and Moti Nagar, Chief Financial Officer, will be holding presentations in London on the day of the results for:

· analysts at 9.00am GMT; and for

· private shareholders at 5.30pm GMT.

 

To register to attend either presentation, please contact laraapstein@luther.co.uk.

 

 

* Excluding the contribution to 2021 and 2020 from NGSoft, a non-core subsidiary that the Group sold in March 2021, and the contribution to 2020 from a significant contract to supply critical care ventilators, which was exceptional in nature.

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

 

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

Forward-looking statements

This document contains forward-looking statements. Those statements reflect the current opinions, evaluations and estimations of the Group's management, and are based on the current data regarding the Group's business as is detailed in this document and in the Group's periodical, interim and immediate reports. The Group does not undertake any obligation or make any representation that actual results and events will be in line with those statements, and stresses that they may differ materially from those statements, due to changes in the Group's business, market, competition, demand for the Group's products or services, general economic factors or other factors that can influence the Group's business and results, and due to information and factors that are currently unknown to the Group's management and that, if known, would affect the management's opinions, evaluations or estimations. The Group will report the actual results and events according to its legal, accounting and regulatory obligations, and does not undertake any other obligation to report them or their deviations from the forward-looking statements, or to update any of the forward-looking statements in this document or to report that it is not valid anymore.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSAFFIRLIF
Date   Source Headline
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital
26th Nov 202012:21 pmRNSBlock Listing Interim Review
23rd Nov 202011:58 amRNSNotice of AGM
5th Oct 20207:00 amRNSMajor new customer for COVID-19 diagnostic tests
27th Aug 20207:00 amRNSBATM secures first tier 1 customer for NFVTime
17th Aug 20207:00 amRNSInterim Results
6th Aug 20206:16 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSNotice of Results
5th Aug 20208:09 amRNSSuccessful proof-of-concept with Vodafone
15th Jul 20207:00 amRNSBATM expands COVID-19 diagnostic tests
25th Jun 20207:00 amRNSBusiness and Trading Update
4th Jun 202012:01 pmRNSHolding(s) in Company
26th May 20207:00 amRNSBlock Listing Application
6th May 202011:45 amRNSHolding(s) in Company
5th May 20207:00 amRNSBATM Launches Antibody Tests for COVID-19
30th Apr 20204:33 pmRNSAnnual Financial Report - DTR 6.3.5 Disclosure
30th Apr 20207:00 amRNSCOVID-19 Update
22nd Apr 20207:00 amRNSBATM receives c. $31m order to produce ventilators
19th Mar 20207:00 amRNSNovamed partnership for COVID-19 diagnostics kit
6th Mar 20207:00 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSFull Year Results
27th Feb 20207:00 amRNSBATM Develops Diagnostics Kit for COVID-19
24th Feb 20207:00 amRNSAward of $4m follow-on cyber contract
12th Feb 20207:00 amRNSNotice of Results
10th Feb 20207:00 amRNSThird international agri-waste contract
7th Feb 20207:00 amRNSHolding(s) in Company
23rd Jan 202011:43 amRNSHolding(s) in Company
22nd Jan 20205:54 pmRNSHolding(s) in Company
7th Jan 20207:00 amRNSFirst commercial agreement for Ador
5th Dec 20193:49 pmRNSResult of AGM
5th Dec 20197:00 amRNS$4m agri-waste treatment contract in Taiwan
7th Nov 20197:00 amRNSNotice of AGM
8th Oct 20197:00 amRNSDirector Share Purchases
7th Oct 20197:00 amRNSExpansion of cyber offering and follow-on contract
2nd Oct 20197:00 amRNSBATM completes delivery under Arm agreement
10th Sep 20197:00 amRNSDirector Shareholding, Issue of Equity and TVR
2nd Sep 20192:19 pmRNSHolding(s) in Company
23rd Aug 20197:00 amRNSBATM joins Tel-Aviv Stock Exchange indices
20th Aug 20192:34 pmRNSHolding(s) in Company
19th Aug 20197:00 amRNSInterim Results
7th Aug 201911:11 amRNSShare Option Exercise, Issue of Equity and TVR
5th Aug 20197:00 amRNSNotice of Results
31st Jul 20192:45 pmRNSReceipt of c. $3.4m from sale of IBC holding
22nd Jul 20197:00 amRNSBATM Advances 5G Strategy with New T-Metro 8104
11th Jul 20199:20 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
11th Jul 20197:45 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
8th Jul 20197:00 amRNSSecondary Listing on the Tel Aviv Stock Exchange
25th Jun 20198:28 amRNSResults of Placing and Subscription
24th Jun 20195:26 pmRNSProposed Fundraise to raise a minimum of US$15m
17th Jun 20197:00 amRNSNew solution under NXP Semiconductors partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.